4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-25-000149
President and CEO sold 495,282 shares at $15.00 ($7,429,230)
- President and CEO acquired 495,282 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/wk-form4_1752268398.xml…